Core Insights - The article discusses the performance and holdings of the Guangfa Healthcare Stock A fund, highlighting its recent net value and returns over various time frames [1] Fund Performance - The latest net value of Guangfa Healthcare Stock A is 2.0837 yuan, reflecting a growth of 0.79% - The fund's return over the past month is 1.25%, ranking 994 out of 1025 in its category - Over the last six months, the fund has achieved a return of 25.87%, ranking 145 out of 986 - Year-to-date, the fund has returned 28.91%, with a ranking of 319 out of 976 [1] Fund Holdings - The top ten holdings of Guangfa Healthcare Stock A account for a total of 50.56%, with the following key positions: - Zai Lab Ltd (9.36%) - Kelun Pharmaceutical (8.62%) - Baillie Gifford (7.47%) - XinNuoWei (4.61%) - Hengrui Medicine (4.45%) - WuXi AppTec (4.07%) - Dong-E E-Jiao (3.07%) - BeiGene Ltd (3.07%) - KAILI Medical (3.01%) - Huatai Medical (2.83%) [1] Fund Background - Guangfa Healthcare Stock A was established on August 10, 2017, and as of June 30, 2025, it has a total scale of 5.247 billion yuan - The fund is managed by Wu Xingwu, who has extensive experience in the investment management field [1][2]
8月21日广发医疗保健股票A净值增长0.79%，今年来累计上涨28.91%
Sou Hu Cai Jing·2025-08-21 12:19